Nureca Limited Board Approves FY26 Results, Appoints New CFO, and Plans AGM
Nureca Limited approved audited FY26 results and consolidated financials. The Board appointed Mr. Chander Kant as CFO effective June 27, 2026, and accepted Mr. Naresh Gupta's resignation. Re-appointments of Mr. Aryan Goyal and Mr. Saurabh Goyal were approved, along with Ms. Smita Goyal's appointment as Additional Director. Capex of up to ₹100 crore for manufacturing expansion was sanctioned. The 10th AGM is set for July 28, 2026.
The approval of financial results, significant capex for expansion, and key management changes including CFO appointment and director re-appointments have a substantial impact on the company's governance, strategic direction, and future growth prospects.
The company reported audited financial results, approved key management appointments and re-appointments, and sanctioned a significant capital expenditure for expansion, indicating positive operational and strategic progress.
Nureca Limited announced the outcome of its Board of Directors meeting held on May 29, 2026. The Board approved the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026, along with the Statutory Auditors' report which had an unmodified opinion.
Key appointments and re-appointments were also approved. M/s MGSG and Associates have been appointed as Internal Auditors for the Financial Year 2026-27. Mr. Chander Kant has been appointed as the new Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) effective June 27, 2026, succeeding Mr. Naresh Gupta, whose resignation as CFO and KMP, effective June 26, 2026, was accepted.
Furthermore, the Board approved the re-appointment of Mr. Aryan Goyal as Whole Time Director & Chief Executive Officer for three years from May 28, 2027, and Mr. Saurabh Goyal as Managing Director for three years from September 3, 2026. Ms. Smita Goyal has been appointed as Additional Director (Whole Time Director) for three years from June 1, 2026. Mr. Aryan Goyal will also retire by rotation at the ensuing 10th AGM.
The company also approved an incremental capex of up to ₹100 crore for plant and machinery to manufacture additional medical devices, healthcare consumables, and hygiene products, and to purchase adjoining land for future expansion at its Punjab facility.
The 10th Annual General Meeting (AGM) is scheduled for Tuesday, July 28, 2026, conducted via video conferencing. The book closure for the AGM will be from July 22, 2026, to July 28, 2026. The cut-off date for remote e-voting is July 21, 2026.
The Board meeting commenced at 3:00 PM and concluded at 4:57 PM.
What to do with a filing like this
Nureca Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Nureca Limited. Read the original for the full detail.